Top

Published in:

Open Access 01-08-2012 | Original Article

Efficacy of radiosynoviorthesis and its impact on chosen inflammatory markers

Authors: Robert Zwolak, Maria Majdan, Marcin Skórski, Beata Chrapko

Published in: Rheumatology International | Issue 8/2012

Abstract

Radiosynoviorthesis is used for the local treatment of recurrent joint effusions and leads to synovium necrosis after radionuclide administration. This procedure provides opportunity to full recovery of normal synovium function after local corticosteroids and systemic modifying drugs failure.

Fischer M, Modder G (2002) Radionuclide therapy of inflammatory joint diseases. Nucl Med Commun 23:829–831PubMedCrossRef

Chrapko B, Zwolak R, Nocuń A, Gołębiewska R, Majdan M (2007) Radiation synovectomy with 90Y colloid in the therapy of recurrent knee joint effusions in patient with inflammatory joint diseases. Rheumatol Int 27:729–734PubMedCrossRef

Mödder G (1995) Radiosynoviorthesis. Involvement of nuclear medicine in rheumatology and orthopaedics. Meckenheim, Germany. Warlich Druck und Verlagsges 22:22–100

Jahangier ZN, Jacobs JW, Bijlsma JWJ, Lafeber FP (2006) Radiation synovectomy with yttrium-90 for persisting arthritis has direct harmful effects on human cartilage that cannot be prevented by coadministration of glucocorticoids: an in vitro study. Ann Rheum Dis 65:1384–1389PubMedCrossRef

Kerschbaumer F (1988) Surgical therapeutic possibilities of the elbow in chronic polyarthritis. Orthopade 17:359–365PubMed

Liao HX, Haynes BF (1995) Role of adhesion molecules in the patogenesis of rheumatoid arthritis. Rheum Dis Clin N Am 21:715–740

Das BK, Moedder G, Pradhan PK, Shukla AK (2004) Concept of radiosynovectomy a novel approach in the treatment of Joint disorders. Indian J Nucl Med 19:1–5

Schutte H, Rau R (1983) Results of radiosynoviorthesis with yttrium 90 in chronic synovitis: a long-term prospective study. II. Effect of general disease parameters. Z Rheumatol 42:271–279PubMed

Spooren PF, Rasker JJ, Arens RP (1985) Synovectomy of the knee with 90Y. Eur J Nucl Med 10:441–445PubMedCrossRef

10.

Abatangelo G, Botti P, Del Bue M, Gei G, Samson JC, Cortivo JC, De Galateo A, Martelli M (1989) Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. I. Biochemical results. Clin Orthop Relat Res 241:278–285PubMed

11.

Abatangelo G, O’Regan M (1995) Hyaluronan biological role and function in articular joints. Eur J Rheumatol Inflamm 15:9–16

12.

Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, Zummer M (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthr Cartil 3:213–225PubMedCrossRef

13.

Hochberg MC (2000) Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. Semin Arthr Rheum 30:2–10CrossRef

14.

Chichibu K, Matsuura T, Schichijo S, Yokoyama MM (1989) Assay of serum hyaluronic acid in clinical application. Clin Chim Acta 181:317–323PubMedCrossRef

15.

Duruözz MT, Turan Y, Cerrahoglu L, Isbilen B (2007) Serum hyaluronic acid levels in patients with ankylosing spondylitis. Clin Rheumatol 12:220–223

16.

Engström-Laurent A, Hällgren R (1985) Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Arthr Rheum 44:83–88

17.

Paimela L, Heiskanen A, Kurki P, Helve T, Leirisalo-Repo M (1991) Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthr Rheum 34:815–821CrossRef

18.

Emlen W, Niebur J, Flanders G, Rutledge J (1996) Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correltion with disease activity. J Rheumatol 23:974–978PubMed

19.

Bezerra MC, Carvalho JF, Prokopowitsch AS, Pereira RMR (2005) RANK, RANKL and osteoprotegerin in arthritic bone loss. Braz J Med Biol Res 38:161–170PubMedCrossRef

20.

Vanderborght A, Linsen L, Thewissen M, Geusens P, Raus J, Stinissen P (2004) Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls. J Rheumatol 31:1483–1490PubMed

21.

Haynes DR, Crotti TN, Loric M, Bain GI, Atkins GJ, Findlay DM (2001) Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology 40:623–630PubMedCrossRef

22.

Boerbooms AM, Buijs WC, Danen M, van de Putte LB, Vandenbroucke JP (1985) Radio-synovectomy in chronic synovitis of the knee joint in patients with rheumatoid arthritis. Eur J Nucl Med 10:446–449PubMedCrossRef

23.

Kampen WU, Brenner W, Kroeger S, Sawula JA, Bohuslavizki KH, Henze E (2001) Long-term results of radiation synovectomy: a clinical follow up. Nucl Med Commun 22:239–246PubMedCrossRef

24.

Gencoglu EA, Aras G, Kucuk O, Atay G, Tutak I, Ataman S, Soylu A, Ibis E (2002) Utility of Tc-99 m human polyclonal immunoglobulin G scintigraphy for assessing the efficacy of yttrium-90 silicate therapy in rheumatoid knee synovitis. Clin Nucl Med 27:395–400PubMedCrossRef

25.

Schneider P, Farahati J, Reiners C (2005) Radiosynovectomy in rheumatology, orthopedics and hemophilia. J Nucl Med 46:48S–54SPubMed

26.

Zwolak R, Majdan M, Zaorska-Rajca J, Chrapko B (2005) The comparison of efficacy and assessment of influence on intensity of inflammatory process in recurrent knee effusions treated by the use of chemical and radiosynoviorthesis. Reumatologia 43:327–330

27.

Chrapko B, Nocuń A, Zwolak R, Majdan M, Gołębiewska R (2007) Three-phase bone scintigraphy in monitoring of rheumatoid gonarthritis treated by yttrium-90 synovectomy. Pol J Environ Stud 16(6A):17–20

Title: Efficacy of radiosynoviorthesis and its impact on chosen inflammatory markers
Authors: Robert Zwolak
Maria Majdan
Marcin Skórski
Beata Chrapko
Publication date: 01-08-2012
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 8/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-011-1956-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Efficacy of radiosynoviorthesis and its impact on chosen inflammatory markers

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2012

G109T polymorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome

Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy

An adult onset Still’s disease mimicking pneumonia

The effects of NSAIDs on types I, II, and III collagen metabolism in a rat osteoarthritis model

Cutaneous manifestations associated with adult-onset Still’s disease: important diagnostic values

Negative serology: could exclude the diagnosis of brucellosis?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page